Visionary Holdings Launches Medical-Grade Stem Cell Anti-Aging Product Line.

Monday, Nov 10, 2025 9:32 am ET1min read

Visionary Holdings Inc., a technology-driven multinational enterprise listed on Nasdaq, has launched its medical-grade stem cell anti-aging product line, targeting the Chinese mainland and broader Asian markets. The product portfolio includes three major categories: Comprehensive Regenerative Package, combining mesenchymal stem cells, NK cell therapy, and AI-based diagnostic. This launch marks a major milestone following GV's entry into the stem cell and medical aesthetics sector earlier this year.

Comments



Add a public comment...
No comments

No comments yet